Replies to post #192088 on Biotech Values

[DewDiligence]

Sprout Pharma’s PR on the Flibanserin panel:

http://finance.yahoo.com/news/fda-advisory-committee-recommends-approval-212100894.html

The proposed brand name is Addyi.

[oldberkeley]

FDA panel backs Sprout's Flibanserin for female HSDD* by 18-6 vote...*Hypoactive Sexual Desire Disorder.

All I can say is that a good companion article is from The Guardian: "Lonely potato syndrome: how I invented a mental disorder."

http://www.theguardian.com/science/brain-flapping/2014/sep/25/lonely-potato-syndrome-mental-disorder-psychological-condition